Noticias de XTLB_US

Noticias del mercado

Últimas noticias sobre XTLB_US — 24 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: XTLB_US ✕ 24 resultados
22/04/2026 XTLB_US — laocai.gov.vn
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Beat Estimates
22/04/2026 XTLB_US — sonla.gov.vn
XTLB XTL Biopharmaceuticals Ltd. American Depositary Shares rises 4.2 percent following release of its 2025 first quarter earnings report. - Stock Community Signals
22/04/2026 XTLB_US — ChartMill
XTLB Stock Price, Quote & Chart | XTL BIOPHARMACEUTICALS-ADR (NASDAQ:XTLB)
18/04/2026 XTLB_US — tayninh.gov.vn
XTL (XTLB) Stock: Is It Overvalued (Modest Decline) 2026-04-18 - Top Picks
18/04/2026 XTLB_US — sonla.gov.vn ES ← EN
Acciones de XTL (XTLB): ¿Está sobrevalorada (disminución modesta)? 2026-04-18 - Cambio de calificación
18/04/2026 XTLB_US — haiphong.gov.vn ES ← EN
Acciones de XTL (XTLB): ¿Están sobrevaloradas (disminución modesta)? 2026-04-18 - Principales selecciones
08/04/2026 XTLB_US — Xã Thanh Hà
What valuation model applies to XTL (XTLB) Stock | Price at $2.40, Down 1.84% - Attention Driven Stocks
06/04/2026 XTLB_US — sonla.gov.vn
Is XTL (XTLB) Stock a Buy Now | Price at $2.36, Down 2.48% - High Attention Stocks
23/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (XTLB) director discloses options on 1,000,000 shares
23/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (XTLB) CFO Niv Segal files initial Form 3
20/03/2026 XTLB_US — Stock Titan
XTL investors will see every 4 ADSs become 1 on March 25
20/03/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals plans 1-for-4 reverse ADS split
20/03/2026 XTLB_US — Stock Titan
XTL Biopharmaceuticals (NASDAQ: XTLB) sets one-for-four reverse ADS ratio change
20/03/2026 XTLB_US — Yahoo Finance
XTL Biopharmaceuticals Announces ADS Ratio Change
18/03/2026 XTLB_US — GuruFocus
Niv Segal Net Worth (2026)
10/03/2026 XTLB_US — Stock Titan ES ← EN
Beyond Air abandona la venta de NeuroNOS y reconsidera los planes neurológicos y contra el cáncer
10/03/2026 XTLB_US — TipRanks
XTL Biopharmaceuticals Ends Acquisition Talks After NeuroNOS LOI Expires
10/03/2026 XTLB_US — The Manila Times ES ← EN
Beyond Air® anuncia la rescisión del acuerdo para vender su filial NeuroNOS a XTL Biopharmaceuticals Ltd.
27/02/2026 XTLB_US — Investing.com
XTL Biopharmaceuticals faces Nasdaq delisting notice
27/02/2026 XTLB_US — Quiver Quantitative
XTL Biopharmaceuticals Limited Faces Nasdaq Delisting Following Insolvency of Subsidiary The Social Proxy

Página 1 de 2

keyboard_arrow_up